| Benchmarking progress in tackling the challenges of intellectual property, and access to medicines in developing countries. | |
| | |
MedLine Citation:
|
PMID: 16710545 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The impact of intellectual property protection in the pharmaceutical sector on developing countries has been a central issue in the fierce debate during the past 10 years in a number of international fora, particularly the World Trade Organization (WTO) and WHO. The debate centres on whether the intellectual property system is: (1) providing sufficient incentives for research and development into medicines for diseases that disproportionately affect developing countries; and (2) restricting access to existing medicines for these countries. The Doha Declaration was adopted at WTO in 2001 and the Commission on Intellectual Property, Innovation and Public Health was established at WHO in 2004, but their respective contributions to tackling intellectual property-related challenges are disputed. Objective parameters are needed to measure whether a particular series of actions, events, decisions or processes contribute to progress in this area. This article proposes six possible benchmarks for intellectual property-related challenges with regard to the development of medicines and ensuring access to medicines in developing countries. |
| | |
Authors:
|
Sisule F Musungu |
Related Documents
:
|
10162925 - Involving doctors in management. a survey of the management development career needs of... 9383495 - Faculty development in emergency medicine. 12680515 - Practice development: purpose, methodology, facilitation and evaluation. 14582945 - The meaning of practice development: evidence from the field. 20824175 - Quantifying the impoverishing effects of purchasing medicines: a cross-country comparis... 8774225 - Body composition assessment in lean and normal-weight young women. |
Publication Detail:
|
Type: Journal Article Date: 2006-05-17 |
Journal Detail:
|
Title: Bulletin of the World Health Organization Volume: 84 ISSN: 0042-9686 ISO Abbreviation: Bull. World Health Organ. Publication Date: 2006 May |
Date Detail:
|
Created Date: 2006-05-19 Completed Date: 2006-07-13 Revised Date: 2009-05-29 |
Medline Journal Info:
|
Nlm Unique ID: 7507052 Medline TA: Bull World Health Organ Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 366-70 Citation Subset: IM |
Affiliation:
|
Programme on Innovation, Access to Knowledge and Intellectual Property at the South Centre, Geneva, Switzerland. musungu@southcentre.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Benchmarking
/
methods* Developing Countries* Health Services Accessibility* Health Services Needs and Demand Humans Intellectual Property* Pharmaceutical Preparations / supply & distribution World Health Organization |
| Chemical | |
Reg. No./Substance:
|
0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Managing the effect of TRIPS on availability of priority vaccines.
Next Document: Essential medicines and human rights: what can they learn from each other?